Commentary · 21 Feb 2026
Conference abstractPublished 19 May 2016
Individualized surgical treatment for patients with advanced-stage ovarian cancer: A contemporary approach
Cornell University, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Worldwide, over 250,000 women are diagnosed with ovarian cancer each year, and about 140,000 women die from the disease. In the USA, estimated new cases are 21,290 and 14,180 deaths from ovarian cancer were recorded in 2015. The standard treatment of advanced ovarian cancer is cytoreductive surgery followed by a combination of platinum-based and taxane-based chemotherapy. The extent of residual disease following cytoreductive surgery correlates with response to adjuvant chemotherapy, rate of complete response at second-look assessment operations, and progression-free survival and overall survival. There is a correlation between the volume of residual disease and the oncologic outcome. Patients undergoing complete surgical resection noted to be having the optimum outcomes. The use of serum CA-125 levels, physical examination and CT imaging have shown to be lacking the accuracy in determining if disease can be optimally debulked. An individualized surgical approach for advanced stage ovarian cancer including ultra-radical debulking to 5 mm residual tumor revealed: Each decrease of 10% in residual tumor volume is followed by an increase of 5.5% in median survival in advanced ovarian cancer patients. Single port access robot assisted laparoscopic surgery is an ideal option. This surgical modality, results in faster recuperation following surgery, enables the early initiation of chemotherapy, improves quality of life (QOL) and an increase in the 5 year relative survival for those patients.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Samir A Farghaly”
